Short-Term Efficacy and Safety Outcomes of Brolucizumab in the Real-Life Clinical Practice

To report the early efficacy and safety outcomes of treatment with intravitreal injections of brolucizumab (IVT-B) in patients presenting neovascular age-related macular degeneration (nAMD) in a tertiary clinical setting. A retrospective case series of patients that received IVT-B with a minimum of...

Descripción completa

Detalles Bibliográficos
Autores principales: Montesel, Andrea, Bucolo, Claudio, Sallo, Ferenc B., Eandi, Chiara M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600267/
https://www.ncbi.nlm.nih.gov/pubmed/34803674
http://dx.doi.org/10.3389/fphar.2021.720345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8600267/
https://www.ncbi.nlm.nih.gov/pubmed/34803674
http://dx.doi.org/10.3389/fphar.2021.720345

Ejemplares similares